{"DataElement":{"publicId":"6414108","version":"1","preferredName":"Prior Viral Exposure And/Or Infectious Disorder Laboratory Procedure Performed Type","preferredDefinition":"A description of the prior viral exposure and/or infection laboratory procedure performed.","longName":"6414035v1.0:6414046v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6414035","version":"1","preferredName":"Prior Viral Exposure And/Or Infectious Disorder Laboratory Procedure Performed","preferredDefinition":"Earlier in time or order._Having to do with a virus._The act of subjecting someone or something to an influencing experience._Used to indicate that either or both of two items or options may be valid._A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact._Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._Executed and carried through to completion.","longName":"6414033v1.0:2241241v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6414033","version":"1","preferredName":"Prior Viral Exposure And/Or Infectious Disorder Laboratory Procedure","preferredDefinition":"Earlier in time or order.:Having to do with a virus.:The act of subjecting someone or something to an influencing experience.:Used to indicate that either or both of two items or options may be valid.:A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.:Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","longName":"6414033v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Exposure","conceptCode":"C17941","definition":"The act of subjecting someone or something to an influencing experience.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D3FE0-8556-497E-E053-F662850A814A","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2241241","version":"1","preferredName":"Performed","preferredDefinition":"Performed; carried out.","longName":"C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FA7953-8839-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-08","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-08","modifiedBy":"ONEDATA","dateModified":"2005-07-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D3FE0-8564-497E-E053-F662850A814A","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"KUMMEROA","dateModified":"2019-12-31","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6414046","version":"1","preferredName":"Viral Exposure And/Or Infectious Disorder Type","preferredDefinition":"Having to do with a virus._The act of subjecting someone or something to an influencing experience._Used to indicate that either or both of two items or options may be valid._A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact._Something distinguishable as an identifiable class based on common qualities.","longName":"6414046v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Toxoplasmosis antibody","valueDescription":"Toxoplasmosis Antibody","ValueMeaning":{"publicId":"6414102","version":"1","preferredName":"Toxoplasmosis Antibody","longName":"6414102","preferredDefinition":"A parasitic disease contracted by the ingestion or fetal transmission of toxoplasma gondii.: A protein made by plasma cells (a type of white blood cell) in response to an antigen (a substance that causes the body to make a specific immune response). Each antibody can bind to only one specific antigen. The purpose of this binding is to help destroy the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxoplasmosis","conceptCode":"C3418","definition":"A parasitic disease contracted by the ingestion or fetal transmission of toxoplasma gondii.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Antibody","conceptCode":"C16295","definition":"A type of protein made by B lymphocytes in response to a foreign substance (antigen). Each antibody only binds to a specific antigen, helping to destroy the antigen directly or by assisting white blood cells to destroy the antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746C57A7-3D5E-3D52-E053-F662850AE6EA","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C57A7-3D77-3D52-E053-F662850AE6EA","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Hepatitis C - NAAT","valueDescription":"Hepatitis C Virus Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"5875310","version":"1","preferredName":"Hepatitis C Virus Nucleic Acid Amplification Test","longName":"5875310","preferredDefinition":"A small, enveloped, positive sense single strand RNA virus in the family Flaviviridae. The genome consists of a single RNA molecule with a single open reading frame.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Virus","conceptCode":"C14312","definition":"A small, enveloped, positive sense single strand RNA virus in the family Flaviviridae. The genome consists of a single RNA molecule with a single open reading frame.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5252E092-AA9C-2108-E053-F662850A8628","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-A9B3-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Anti-HCV","valueDescription":"Hepatitis C Antibody","ValueMeaning":{"publicId":"4396020","version":"1","preferredName":"Hepatitis C Antibody","longName":"4396020","preferredDefinition":"An antibody produced by B-lymphocytes in response to hepatitis C virus infection","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis C Antibody","conceptCode":"C116400","definition":"An antibody produced by B-lymphocytes in response to hepatitis C virus infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEBEAA66-DEE6-868D-E040-BB89AD43726E","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"COLBERTM","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-A9BD-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Hepatitis B - NAAT","valueDescription":"Hepatitis B Virus Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"5875311","version":"1","preferredName":"Hepatitis B Virus Nucleic Acid Amplification Test","longName":"5875311","preferredDefinition":"Hepatitis B Virus (HBV) is the prototype of the Hepadnavirus Family.  Included in the family are the Woodchuck Hepatitis Virus (WHV) and the Duck Hepatitis B Virus (DHBV) which provide animal models of infection.  The HBV genome is a partially double stranded circular DNA.  A viral reverse transcriptase is bound to the 5' extremity of the long strand.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus","conceptCode":"C14215","definition":"Hepatitis B Virus (HBV) is the prototype of the Hepadnavirus Family.  Included in the family are the Woodchuck Hepatitis Virus (WHV) and the Duck Hepatitis B Virus (DHBV) which provide animal models of infection.  The HBV genome is a partially double stranded circular DNA.  A viral reverse transcriptase is bound to the 5' extremity of the long strand.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5252E092-AAD6-2108-E053-F662850A8628","latestVersionIndicator":"Yes","beginDate":"2017-06-19","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-06-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-A9D1-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"HBsAg","valueDescription":"Hepatitis B Surface Antigen","ValueMeaning":{"publicId":"3370219","version":"1","preferredName":"Hepatitis B Surface Antigen","longName":"3370219","preferredDefinition":"Any one of the hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus HBsAg Surface Protein Antigen","conceptCode":"C62786","definition":"Any one of the hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B80317DA-4804-5693-E040-BB89AD432471","latestVersionIndicator":"Yes","beginDate":"2012-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-A9DB-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Anti HBc","valueDescription":"Hepatitis B Virus Core Antibody","ValueMeaning":{"publicId":"3370218","version":"1","preferredName":"Hepatitis B Virus Core Antibody","longName":"3370218","preferredDefinition":"An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus Core Antibody","conceptCode":"C62797","definition":"An antibody produced by B lymphocytes to the hepatitis B core antigen as part of the immune response to hepatitis B viral infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B80317DA-47E1-5693-E040-BB89AD432471","latestVersionIndicator":"Yes","beginDate":"2012-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-02","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-A9E5-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Hepatitis B surface antibody","valueDescription":"Hepatitis B Virus Surface Antibody","ValueMeaning":{"publicId":"6414047","version":"1","preferredName":"Hepatitis B Virus Surface Antibody","longName":"6414047","preferredDefinition":"An antibody produced by B lymphocytes to the hepatitis B surface antigen as part of the immune response to hepatitis B viral infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis B Virus Surface Antibody","conceptCode":"C62796","definition":"An antibody produced by B lymphocytes to the hepatitis B surface antigen as part of the immune response to hepatitis B viral infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746C722A-A9F1-6076-E053-F662850A71E1","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-AA0A-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Anti-EBV","valueDescription":"Epstein-Barr Virus Antibody","ValueMeaning":{"publicId":"4719095","version":"1","preferredName":"Epstein-Barr Virus Antibody","longName":"4719095","preferredDefinition":"Any immunoglobulin that recognizes the Epstein-Barr virus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Epstein-Barr Virus Antibody","conceptCode":"C118489","definition":"Any immunoglobulin that recognizes the Epstein-Barr virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F50D56C-C959-04C6-E050-BB89AD430837","latestVersionIndicator":"Yes","beginDate":"2015-02-17","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-02-17","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-AA1E-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"HTLV1 antibody","valueDescription":"HTLV-1 Antibody","ValueMeaning":{"publicId":"4791992","version":"1","preferredName":"HTLV-1 Antibody","longName":"4791992","preferredDefinition":"An antibody produced by B lymphocytes in response to human T-cell leukemia virus type 1 infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HTLV-1 Antibody","conceptCode":"C71691","definition":"An antibody produced by B lymphocytes in response to human T-cell leukemia virus type 1 infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13C4625A-16B8-E2A7-E050-BB89AD43622B","latestVersionIndicator":"Yes","beginDate":"2015-04-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2015-04-15","modifiedBy":"ONEDATA_WA","dateModified":"2023-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746C722A-AA32-6076-E053-F662850A71E1","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"HIV - NAAT","valueDescription":"HIV Infection Nucleic Acid Amplification Test","ValueMeaning":{"publicId":"6414048","version":"1","preferredName":"HIV Infection Nucleic Acid Amplification Test","longName":"6414048","preferredDefinition":"any state accompanied by evidence of HIV in the body (positive test for HIV genome, cDNA, proteins, antigens, or antibodies); may be medically asymptomatic or symptomatic; prefer AIDS when appropriate.: Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HIV Infection","conceptCode":"C3108","definition":"An infection caused by the human immunodeficiency virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nucleic Acid Amplification Test","conceptCode":"C20055","definition":"Any of various amplification and detection strategies applied to detection of virus contamination in donor blood.  Specifically designed to detect recently infected individuals during the latency period before seroconversion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746DF9A4-F907-0A70-E053-F662850AC6CF","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746DF9A4-F920-0A70-E053-F662850AC6CF","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"HIV antibody","valueDescription":"HIV Antibody","ValueMeaning":{"publicId":"6414049","version":"1","preferredName":"HIV Antibody","longName":"6414049","preferredDefinition":"Produced by B-cells, human immunodeficiency virus (HIV) antibodies reacts with HIV antigens. HIV is a virus which affects white blood cells and eventually destroys the body's natural ability to fight infections.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"HIV Antibody","conceptCode":"C16688","definition":"Produced by B-cells, human immunodeficiency virus (HIV) antibodies reacts with HIV antigens. HIV is a virus which affects white blood cells and eventually destroys the body's natural ability to fight infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746DF9A4-F92C-0A70-E053-F662850AC6CF","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"746DF9A4-F945-0A70-E053-F662850AC6CF","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"3104692","version":"1","preferredName":"Not Done","longName":"3104692v1.00","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88084310-6796-6259-E040-BB89AD4311C3","latestVersionIndicator":"Yes","beginDate":"2010-06-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-06-02","modifiedBy":"RAGUNATHANU","dateModified":"2022-05-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ABC02AE8-8706-65FE-E053-4EBD850AFB73","beginDate":"2020-07-31","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-31","modifiedBy":"ONEDATA","dateModified":"2020-07-31","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB727181-3319-45F4-E053-4EBD850A47D2","beginDate":"2020-07-27","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-27","modifiedBy":"ONEDATA","dateModified":"2020-07-27","deletedIndicator":"No"},{"value":"Not tested","valueDescription":"Not Tested","ValueMeaning":{"publicId":"3918247","version":"1","preferredName":"Not Tested","longName":"3918247","preferredDefinition":"Indicates that a test was not performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Tested","conceptCode":"C101887","definition":"Indicates that a test was not performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8673FC8-BC14-9D61-E040-BB89AD431A7D","latestVersionIndicator":"Yes","beginDate":"2013-10-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AB727181-3323-45F4-E053-4EBD850A47D2","beginDate":"2020-07-27","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-27","modifiedBy":"ONEDATA","dateModified":"2020-07-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6414113","version":"1","preferredName":"Viral Exposure And/Or Infectious Disorder Type","preferredDefinition":"Having to do with a virus.:The act of subjecting someone or something to an influencing experience.:Used to indicate that either or both of two items or options may be valid.:A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.:Something distinguishable as an identifiable class based on common qualities.","longName":"6414113v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Exposure","conceptCode":"C17941","definition":"The act of subjecting someone or something to an influencing experience.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746DAD68-D383-71AE-E053-F662850ADB15","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"ONEDATA","dateModified":"2018-08-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"746C722A-A993-6076-E053-F662850A71E1","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"MALUMK","dateModified":"2020-07-31","changeDescription":".Added PVs for 2000r6 07/27/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"base_inf_pr_vir_exp_infec_typ","type":"NMDP_FN","context":"NHLBI"},{"name":"base_infect_pr_vir_exp_infec_typ","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_CC_pr_vir_exp_infec_typ","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the prior viral expo","type":"Preferred Question Text","description":"What was the prior viral exposure and/or infection laboratory procedure performed?","url":null,"context":"NHLBI"},{"name":"Prior viral exposure / infection","type":"Alternate Question Text","description":"Prior viral exposure / infection","url":null,"context":"NHLBI"},{"name":"Prior viral exposure / infection","type":"Application Standard Question Text","description":"Prior viral exposure / infection","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"746DBCF7-15F1-082E-E053-F662850ABC31","latestVersionIndicator":"Yes","beginDate":"2018-08-27","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2018-08-27","modifiedBy":"KUMMEROA","dateModified":"2022-05-25","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}